Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 30Sanofi

02 2Regeneron Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 300 mg

Packaging : Pre-filled pen 3 2ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 2 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 6 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 75 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 6 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Norway

Alirocumab

Brand Name : Praluent

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 150 mg/ml

Packaging : Pre-filled pen 2 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

Sanofi Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 23/09/2015

Application Number : 20141231000095

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 23/09/2015

Application Number : 20141231000118

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 19/08/2020

Application Number : 20191113000040

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date : 23/09/2015

Application Number : 20141231000088

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

12

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Approved

Registration Country : Sweden

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date : 23/09/2015

Application Number : 20141231000101

Regulatory Info : Approved

Registration Country : Sweden

Sanofi Company Banner

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 75mg/ml

Packaging :

Approval Date : 22/04/2016

Application Number : 65661

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

14

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date : 22/04/2016

Application Number : 65661

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

15

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 75mg/ml

Packaging :

Approval Date : 22/04/2016

Application Number : 65882

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

16

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Allowed

Registration Country : Switzerland

Alirocumab

Brand Name : Praluent

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date : 22/04/2016

Application Number : 65882

Regulatory Info : Allowed

Registration Country : Switzerland

Sanofi Company Banner

17

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : SOLUTION

Dosage Strength : 75MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2453819

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

18

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : SOLUTION

Dosage Strength : 150MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2453835

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

19

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Schedule D

Registration Country : Canada

ALIROCUMAB

Brand Name : PRALUENT

Dosage Form : SOLUTION

Dosage Strength : 300MG/2ML

Packaging :

Approval Date :

Application Number : 2547732

Regulatory Info : Schedule D

Registration Country : Canada

Sanofi Company Banner

20

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

ALIROCUMAB

Brand Name : PRALUENT 75 MG

Dosage Form : INJ

Dosage Strength : 75mg

Packaging : 1X2mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner